Earnings Call · Q2 FY2021·2021-07-29

Q2 21EPS +19.85%·Rev n/aQ1 21EPS +24.78%·Rev n/aQ4 20EPS +48.62%·Rev n/aQ3 20EPS +6.12%·Rev n/a⚠ consensus missing

LIGAND PHARMACEUTICALS INC LGND

Simon Latimer — Conference Call Host

John Higgins — Chief Executive Officer (CEO)

Matthew Korenberg — Chief Financial Officer (CFO)

Matthew Foehr — Chief Operating Officer (COO)

−4.6%1d on move date−4.1% vs SPY3d−6.6%5d−8.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGND calls or request research access.

More LGND calls Browse calls Request research access